P P Fang1, W M Harmening1, P L Müller1, M Lindner1, T U Krohne1, F G Holz2. 1. Universitäts-Augenklinik Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland. 2. Universitäts-Augenklinik Bonn, Ernst-Abbe-Str. 2, 53127, Bonn, Deutschland. frank.holz@ukb.uni-bonn.de.
Abstract
BACKGROUND: Optical coherence tomography angiography (OCT-A) is a new diagnostic non-invasive method by which the vascular structures of the retina and choroid can be visualized three-dimensionally without need for using fluorescence dyes. The technology of OCT-A is an advancement of the OCT. By means of more powerful software and hardware used for OCT-A not only morphological but also retinal and choroidal vascular perfusion analyses can be performed. In this article, the principles and applications of OCT-A are discussed and compared to other non-invasive diagnostic devices for visualization of the retinal and choroidal blood circulation. METHODS: This article is based on a selective literature review and analyses of own data. RESULTS: The advantages of OCT-A include easy application without the need for mydriasis or intravenous injection of fluorescence dyes and also the exact three-dimensional localization of vascular changes. In the case of retinal pathologies there is a considerable difference between software-assisted automatic segmentation and the real architecture of the retina, which must be taken into consideration in the clinical interpretation. CONCLUSION: Of all noninvasive devices for visualization of the retinal and choroidal circulation, OCT-A is the only one which can already be implemented into the clinical routine. With this novel imaging device retinal and choroidal alterations can be visualized in a depth- selective manner and without masking affects, such as pooling or staining phenomena.
BACKGROUND: Optical coherence tomography angiography (OCT-A) is a new diagnostic non-invasive method by which the vascular structures of the retina and choroid can be visualized three-dimensionally without need for using fluorescence dyes. The technology of OCT-A is an advancement of the OCT. By means of more powerful software and hardware used for OCT-A not only morphological but also retinal and choroidal vascular perfusion analyses can be performed. In this article, the principles and applications of OCT-A are discussed and compared to other non-invasive diagnostic devices for visualization of the retinal and choroidal blood circulation. METHODS: This article is based on a selective literature review and analyses of own data. RESULTS: The advantages of OCT-A include easy application without the need for mydriasis or intravenous injection of fluorescence dyes and also the exact three-dimensional localization of vascular changes. In the case of retinal pathologies there is a considerable difference between software-assisted automatic segmentation and the real architecture of the retina, which must be taken into consideration in the clinical interpretation. CONCLUSION: Of all noninvasive devices for visualization of the retinal and choroidal circulation, OCT-A is the only one which can already be implemented into the clinical routine. With this novel imaging device retinal and choroidal alterations can be visualized in a depth- selective manner and without masking affects, such as pooling or staining phenomena.
Authors: Wolfgang Wieser; Benjamin R Biedermann; Thomas Klein; Christoph M Eigenwillig; Robert Huber Journal: Opt Express Date: 2010-07-05 Impact factor: 3.894
Authors: Brian White; Mark Pierce; Nader Nassif; Barry Cense; B Park; Guillermo Tearney; Brett Bouma; Teresa Chen; Johannes de Boer Journal: Opt Express Date: 2003-12-15 Impact factor: 3.894
Authors: Toco Y P Chui; Michael Dubow; Alexander Pinhas; Nishit Shah; Alexander Gan; Rishard Weitz; Yusufu N Sulai; Alfredo Dubra; Richard B Rosen Journal: Biomed Opt Express Date: 2014-03-13 Impact factor: 3.732
Authors: Yanping Huang; Qinqin Zhang; Mariana R Thorell; Lin An; Mary K Durbin; Michal Laron; Utkarsh Sharma; Giovanni Gregori; Philip J Rosenfeld; Ruikang K Wang Journal: Ophthalmic Surg Lasers Imaging Retina Date: 2014 Sep-Oct Impact factor: 1.300
Authors: Liang Liu; Yali Jia; Hana L Takusagawa; Alex D Pechauer; Beth Edmunds; Lorinna Lombardi; Ellen Davis; John C Morrison; David Huang Journal: JAMA Ophthalmol Date: 2015-09 Impact factor: 7.389
Authors: Kari V Vienola; Boy Braaf; Christy K Sheehy; Qiang Yang; Pavan Tiruveedhula; David W Arathorn; Johannes F de Boer; Austin Roorda Journal: Biomed Opt Express Date: 2012-10-24 Impact factor: 3.732
Authors: Boy Braaf; Kari V Vienola; Christy K Sheehy; Qiang Yang; Koenraad A Vermeer; Pavan Tiruveedhula; David W Arathorn; Austin Roorda; Johannes F de Boer Journal: Biomed Opt Express Date: 2012-12-11 Impact factor: 3.732
Authors: WooJhon Choi; Kathrin J Mohler; Benjamin Potsaid; Chen D Lu; Jonathan J Liu; Vijaysekhar Jayaraman; Alex E Cable; Jay S Duker; Robert Huber; James G Fujimoto Journal: PLoS One Date: 2013-12-11 Impact factor: 3.240